Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Manipal Health EnterprisesNSE:MANIPALHOS -3.30%13 ROE % is 9.19% as of Mar. 2026, which is 12% below its 10-year median of 10.43. GuruFocus rates NSE:MANIPALHOS with a GF Score™ of 13/100. The stock has 1 warning sign investors should review. Among 630 Healthcare Providers & Services companies, Manipal Health Enterprises ranks better than 59.84% on this metric.
The historical rank and industry rank for Manipal Health Enterprises's ROE % or its related term are showing as below:
NSE:MANIPALHOS'
s ROE % Range Over the Past 10 Years
Min: 9.19 Med: 10.43 Max: 14.8
Current: 9.19
During the past 3 years, Manipal Health Enterprises's highest ROE % was 14.80%. The lowest was 9.19%. And the median was 10.43%.
NSE:MANIPALHOS's ROE % is ranked better than 59.84% of 630
companies
in the Healthcare Providers & Services industry
Industry Median: 6.22
vs NSE:MANIPALHOS: 9.19
Manipal Health Enterprises (NSE:MANIPALHOS) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is one times the annual (Mar. 2026) net income data. The Revenue data used here is one times the annual (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Manipal Health Enterprises ROE % Chart
Manipal Health Enterprises Annual Data
Trend
Mar24
Mar25
Mar26
ROE %
14.80
10.43
9.19
Manipal Health Enterprises Semi-Annual Data
Mar24
Mar25
Mar26
ROE %
14.80
10.43
9.19
NSE:MANIPALHOS vs : ROE % Comparison
For the Medical Care Facilities subindustry, Manipal Health Enterprises's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Manipal Health Enterprises ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Manipal Health Enterprises's ROE % distribution charts can be found below:
* The bar in red indicates where Manipal Health Enterprises's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is one times the annual (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Manipal Health Enterprises (NSE:MANIPALHOS) has a ROE % of 9.19% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Manipal Health Enterprises and its competitors. This is 12% below median its historical median of 10.43. Over the past decade, Manipal Health Enterprises' ROE % has ranged from 9.19 to 14.80. According to the industry distribution chart, Manipal Health Enterprises ranks #253 out of 630 companies in the Healthcare Providers & Services industry, placing it in the top 40.2%.
Is Manipal Health Enterprises' ROE % too high?
Manipal Health Enterprises' current ROE % of 9.19% is 12% below median its 10-year median of 10.43. Over the past 10 years, this metric has ranged from a low of 9.19 to a high of 14.80. The Healthcare Providers & Services industry median ROE % is 6.22. Manipal Health Enterprises' value of 9.19% is 47.7% above this industry median. Based on the distribution chart, Manipal Health Enterprises ranks #253 out of 630 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Manipal Health Enterprises has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Manipal Health Enterprises' ROE % compare to ?
According to the Healthcare Providers & Services industry distribution chart, Manipal Health Enterprises ranks #253 out of 630 companies for ROE %. This puts Manipal Health Enterprises in the upper half of its industry. The industry median ROE % is 6.22. Manipal Health Enterprises' value of 9.19% is 47.7% above this benchmark. Historically, Manipal Health Enterprises' own ROE % has ranged from 9.19 to 14.80 over the past decade. While the company's 10-year median is 10.43 vs. the industry median of 6.22, Manipal Health Enterprises has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 6.22, based on 630 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Manipal Health Enterprises's current ROE % of 9.19% is 47.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Manipal Health Enterprises and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 6.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Manipal Health Enterprises's current ROE % is 9.19%, which is 12% below median its own 10-year median of 10.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Manipal Health Enterprises stock overvalued right now?
Manipal Health Enterprises (NSE:MANIPALHOS) has a current ROE % of 9.19%. The current ROE % is 9.19%, which is 12% below median its 10-year median of 10.43 and 47.7% above the Healthcare Providers & Services industry median of 6.22. Manipal Health Enterprises' overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Manipal Health Enterprises (NSE:MANIPALHOS), the current ROE % is 9.19% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Manipal Health Enterprises Ltd is engaged in the business of running/managing hospitals and providing healthcare services. The company operates through various Hospitals/clinics providing Healthcare services and diagnostic centres in India. It offers clinical services across several specialties, with a focus on tertiary and quaternary care, particularly in cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics, and renal sciences. It has a single business segment, namely engaged in the business of healthcare services. The company generates revenue by providing inpatient care at its hospitals.
13GF Score
Get the complete analysis for NSE:MANIPALHOS
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MANIPALHOS has been successfully added to your 
